Upward Move: Jeff Winton

Jeff Winton
Jeff Winton

The typical career arc in pharma marketing often includes a stint “carrying the bag,” and a few years on the agency side. A more unconventional route, however, may include growing up on a farm, studying animal science and pursuing a degree in theology. But for Jeff Winton, Astellas's newly appointed SVP and chief communications officer, that extraordinary path to the C-Suite has been a rewarding one.

“While all my friends were all going back for MBAs, I decided I was going to do something totally different,” he recalls, “I was always very interested in world religion. I think back to that program—it made me a better manager. A lot of it was about understanding the human condition. That's what managers deal with every day.”

That understanding would follow him into public affairs, and his beginning in pharma.

“My very first job in this industry was in patient advocacy for Hoffmann-La Roche as an HIV/AIDS advocate in the early days of the pandemic. Needless to say, it was a very interesting time to enter the pharma industry,” he says, “And it was one of the most satisfying jobs I've ever had. “

Now, Winton finds himself in a position that hitherto had not existed at Astellas.

“It's a brand new role,” he affirms, “But my responsibilities here are a matter of building on a lot of good work that's already been done. We are looking to further integrate with other parts of the organization—particularly advocacy—and formalize the ways in which we work together.”

Outside of his hopes for how the organization will “work together,” Winton's beginnings inform his view on how the the industry should act.

“I'm the first person in my family to go to college. My dad was a farmer and drove a schoolbus. Hard-working blue collar people treat others with respect,” he says, “You have to treat others with respect. Regardless of whether they can do something for you or not. You never know who is going to end up where.”


Next Article in Careers


How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy


Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.